Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

Translated title of the contribution: Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

D.M.O. Pruissen, F.R. Rosendaal, J.W. Gorter, A. Garcia, L.J. Kappelle, A. Algra

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionHaemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.
Original languageUndefined/Unknown
Pages (from-to)1660-1665
Number of pages6
JournalJournal of Neurology
Volume254
Issue number12
Publication statusPublished - 2007

Cite this